Author

Lennard Gilissen

NEITHER INFLAMMATORY BOWEL DISEASE NOR IMMUNOSUPPRESSANTS ARE ASSOCIATED WITH AN INCREASED RISK FOR SEVERE COVID-19. AN OBSERVATIONAL DUTCH COHORT-STUDY
NEITHER INFLAMMATORY BOWEL DISEASE NOR IMMUNOSUPPRESSANTS ARE ASSOCIATED WITH AN INCREASED RISK FOR SEVERE COVID-19. AN OBSERVATIONAL DUTCH COHORT-STUDY

NEITHER INFLAMMATORY BOWEL DISEASE NOR IMMUNOSUPPRESSANTS ARE ASSOCIATED WITH AN INCREASED RISK FOR SEVERE COVID-19. AN OBSERVATIONAL DUTCH COHORT-STUDY
NEITHER INFLAMMATORY BOWEL DISEASE NOR IMMUNOSUPPRESSANTS ARE ASSOCIATED WITH AN INCREASED RISK FOR SEVERE COVID-19. AN OBSERVATIONAL DUTCH COHORT-STUDY

Lennard Gilissen  et al.

THERAPEUTIC DRUG MONITORING OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS - TUMMY TRIAL
THERAPEUTIC DRUG MONITORING OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS - TUMMY TRIAL

Lennard Gilissen  et al.

OCTREOTIDE SIGNIFICANTLY REDUCES TRANSFUSION REQUIREMENTS COMPARED TO STANDARD CARE IN PATIENTS WITH ANGIODYSPLASIA-RELATED ANAEMIA: A MULTICENTRE RANDOMISED CONTROLLED TRIAL
OCTREOTIDE SIGNIFICANTLY REDUCES TRANSFUSION REQUIREMENTS COMPARED TO STANDARD CARE IN PATIENTS WITH ANGIODYSPLASIA-RELATED ANAEMIA: A MULTICENTRE RANDOMISED CONTROLLED TRIAL

Lennard Gilissen  et al.

Item 1 - 4 / 4
1